Skip to main content English

The Future of Neuromodulation in Psychiatry, a big picture and how this field may mature. Prof. Harold A. Sackeim, PhD; New York

Events

05. November 2025
14:00 - 16:00

Universitätsklinikum AKH Wien
Hörsaalzentrum
Ebene 07

Hörsaal 5

Harold A. Sackeim, PhD

Programm

Brief Biographical Sketch

Harold A. Sackeim, PhD

Dr. Sackeim is Professor, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, the Founding Editor, Brian Stimulation: Basic, Translational, and Clinical Research in Neuromodulation, and co-chair of the 6th International Brain Stimulation Conference.

For many years he served as Chief of the Department of Biological Psychiatry at the New York State Psychiatric Institute and Columbia University. His work has spanned psychopharmacology, neuromodulation, and the neurobiology of mood disorders. He served as Science Advisor for STAR*D and developed key methods to evaluate the treatment resistance. In five consecutive RCTs at Columbia and several multisite studies, his work revolutionized the practice of ECT, fundamentally changing how the treatment is performed and our understanding of its mechanisms.  Dr. Sackeim has also helped pioneer the use TMS and VNS in treatment-resistant mood disorders.  He currently chairs the largest prospective registry of depressed patients ever to receive a specific treatment, in this case, TMS. He is the originator of Magnetic Seizure Therapy (MST) and Focal-Electrically-Administered Seizure Therapy (FEAST), currently undergoing international trials. Dr. Sackeim has nearly 500 publications and has received numerous prestigious awards.